Literature DB >> 23741978

Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib.

Massimo Gentile1, Maurizio Guido, Eugenio Lucia, Ernesto Vigna, Carla Mazzone, Anna Grazia Recchia, Fortunato Morabito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23741978     DOI: 10.3109/10428194.2013.811240

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  4 in total

1.  The impact of dasatinib on pregnancy outcomes.

Authors:  Jorge E Cortes; Elisabetta Abruzzese; Ekaterina Chelysheva; Mausumee Guha; Nicola Wallis; Jane F Apperley
Journal:  Am J Hematol       Date:  2015-10-12       Impact factor: 10.047

2.  Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.

Authors:  Anna Grazia Recchia; Nadia Caruso; Sabrina Bossio; Mariavaleria Pellicanò; Laura De Stefano; Stefania Franzese; Angela Palummo; Vincenzo Abbadessa; Eugenio Lucia; Massimo Gentile; Ernesto Vigna; Clementina Caracciolo; Antolino Agostino; Sara Galimberti; Luciano Levato; Fabio Stagno; Stefano Molica; Bruno Martino; Paolo Vigneri; Francesco Di Raimondo; Fortunato Morabito
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

3.  Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review.

Authors:  Zsolt Szakács; Péter Jenő Hegyi; Nelli Farkas; Péter Hegyi; Márta Balaskó; Adrienn Erős; Szabina Szujó; Judit Pammer; Bernadett Mosdósi; Mária Simon; Arnold Nagy; Gabriella Für; Alizadeh Hussain
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

Review 4.  Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update.

Authors:  Rossella Mazzilli; Alberto Vaiarelli; Lisa Dovere; Danilo Cimadomo; Nicolò Ubaldi; Susanna Ferrero; Laura Rienzi; Francesco Lombardo; Andrea Lenzi; Herman Tournaye; Filippo Maria Ubaldi
Journal:  Asian J Androl       Date:  2022 Mar-Apr       Impact factor: 3.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.